These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 6175368)
1. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain? Invernizzi R; Kmieciak-Kolada K; Samanin R Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368 [TBL] [Abstract][Full Text] [Related]
2. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511 [TBL] [Abstract][Full Text] [Related]
3. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms. Borroni E; Ceci A; Garattini S; Mennini T J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286 [TBL] [Abstract][Full Text] [Related]
4. Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats. Fuller RW; Snoddy HD; Hemrick SK Proc Soc Exp Biol Med; 1978 Feb; 157(2):202-5. PubMed ID: 622385 [No Abstract] [Full Text] [Related]
5. The effect of D-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats. Datla KP; Curzon G Eur J Pharmacol; 1997 Aug; 333(1):27-31. PubMed ID: 9311657 [TBL] [Abstract][Full Text] [Related]
6. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. Borsini F; Bendotti C; Aleotti A; Samanin R; Garattini S Pharmacol Res Commun; 1982 Jul; 14(7):671-8. PubMed ID: 6215652 [No Abstract] [Full Text] [Related]
7. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. Johnson GJ; Leis LA; Dunlop PC; Weir EK J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103 [TBL] [Abstract][Full Text] [Related]
8. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine. Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366 [TBL] [Abstract][Full Text] [Related]
9. Fenfluramine and 5-hydroxytryptamine?. Part 1: Is fenfluramine or norfenfluramine involved in the decrease of brain 5-hydroxytryptamine. Duhault J; Malen C; Boulanger M; Voisin C; Beregi L; Schmitt H Arzneimittelforschung; 1975 Nov; 25(11):1755-8. PubMed ID: 1243082 [TBL] [Abstract][Full Text] [Related]
10. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release. Oluyomi AO; Gibson EL; Barnfield AM; Curzon G Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. MartÃn F; Artigas F J Neurochem; 1992 Sep; 59(3):1138-44. PubMed ID: 1379630 [TBL] [Abstract][Full Text] [Related]
12. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain. Clausing P; Newport GD; Bowyer JF J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806 [TBL] [Abstract][Full Text] [Related]
13. Anorectic effect and brain concentrations of D-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms. Caccia S; Anelli M; Fracasso C; Frittoli E; Giorcelli P; Gobbi M; Taddei C; Garattini S; Mennini T Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):306-12. PubMed ID: 8479546 [TBL] [Abstract][Full Text] [Related]
14. The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine. Welch JT; Lim DS Bioorg Med Chem; 2007 Nov; 15(21):6659-66. PubMed ID: 17765553 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of fenfluramine to norfenfluramine in guinea-pigs. Fuller RW; Snoddy HD; Perry KW J Pharm Pharmacol; 1988 Jun; 40(6):439-41. PubMed ID: 2458444 [TBL] [Abstract][Full Text] [Related]
16. Hyper- and hyposensitivity of central serotonin receptors:[3H]serotonin binding and functional studies in the rat. Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F Brain Res; 1980 May; 189(2):449-57. PubMed ID: 7189434 [TBL] [Abstract][Full Text] [Related]
17. The fenfluramine metabolite (+)-norfenfluramine is vasoactive. Ni W; Li MW; Thakali K; Fink GD; Watts SW J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat. Mennini T; Fracasso C; Cagnotto A; Bergami A; Frittoli E; Gobbi M; Caccia S; Garattini S Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):641-7. PubMed ID: 8738297 [TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain. Invernizzi R; Fracasso C; Caccia S; Garattini S; Samanin R Neuropharmacology; 1991 Feb; 30(2):119-23. PubMed ID: 2030819 [TBL] [Abstract][Full Text] [Related]
20. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]